These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 3904869

  • 21. Characterization of an antiglycoprotein Ib monoclonal antibody that specifically inhibits platelet-thrombin interaction.
    Mazurov AV, Vinogradov DV, Vlasik TN, Repin VS, Booth WJ, Berndt MC.
    Thromb Res; 1991 Jun 15; 62(6):673-84. PubMed ID: 1718052
    [Abstract] [Full Text] [Related]

  • 22. Antithrombotic effect of crotalin, a platelet membrane glycoprotein Ib antagonist from venom of Crotalus atrox.
    Chang MC, Lin HK, Peng HC, Huang TF.
    Blood; 1998 Mar 01; 91(5):1582-9. PubMed ID: 9473223
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Glycoprotein Ib has a partial role in platelet-von Willebrand factor collagen interaction.
    Aihara M, Tamura K, Kawarada R, Okawa K, Yoshida Y.
    Thromb Haemost; 1988 Oct 31; 60(2):182-7. PubMed ID: 3064358
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.
    Tornai I, Arnout J, Deckmyn H, Peerlinck K, Vermylen J.
    J Clin Invest; 1993 Jan 31; 91(1):273-82. PubMed ID: 8423224
    [Abstract] [Full Text] [Related]

  • 31. Heterogeneity of drug-dependent platelet antigens and their antibodies in quinine- and quinidine-induced thrombocytopenia: involvement of glycoproteins Ib, IIb, IIIa, and IX.
    Pfueller SL, Bilston RA, Logan D, Gibson JM, Firkin BG.
    Blood; 1988 Oct 31; 72(4):1155-62. PubMed ID: 2971407
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Shear stress-induced von Willebrand factor binding to platelet glycoprotein Ib initiates calcium influx associated with aggregation.
    Chow TW, Hellums JD, Moake JL, Kroll MH.
    Blood; 1992 Jul 01; 80(1):113-20. PubMed ID: 1611079
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. High shear stress attenuates agonist-induced, glycoprotein IIb/IIIa-mediated platelet aggregation when von Willebrand factor binding to glycoprotein Ib/IX is blocked.
    Iijima K, Murata M, Nakamura K, Kitaguchi T, Handa M, Watanabe K, Fujimura Y, Yoshioka A, Ikeda Y.
    Biochem Biophys Res Commun; 1997 Apr 28; 233(3):796-800. PubMed ID: 9168936
    [Abstract] [Full Text] [Related]

  • 38. Plasmin effect on platelet glycoprotein Ib-von Willebrand factor interactions.
    Adelman B, Michelson AD, Loscalzo J, Greenberg J, Handin RI.
    Blood; 1985 Jan 28; 65(1):32-40. PubMed ID: 3155489
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Type IIB von Willebrand factor with normal sialic acid content induces platelet aggregation in the absence of ristocetin. Role of platelet activation, fibrinogen, and two distinct membrane receptors.
    De Marco L, Mazzuccato M, Grazia Del Ben M, Budde U, Federici AB, Girolami A, Ruggeri ZM.
    J Clin Invest; 1987 Aug 28; 80(2):475-82. PubMed ID: 3038958
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.